Waste Management
Compare Stocks
4 / 10Stock Comparison
AWX vs USPH vs CWST vs AFCG
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Care Facilities
Waste Management
REIT - Specialty
AWX vs USPH vs CWST vs AFCG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Waste Management | Medical - Care Facilities | Waste Management | REIT - Specialty |
| Market Cap | $10M | $897M | $5.35B | $73M |
| Revenue (TTM) | $85M | $695M | $1.88B | $6M |
| Net Income (TTM) | $585K | $11M | $7M | $-20M |
| Gross Margin | 15.3% | 22.0% | 17.4% | -76.6% |
| Operating Margin | 3.7% | 12.2% | 4.5% | -124.7% |
| Forward P/E | 30.7x | 20.6x | 63.9x | — |
| Total Debt | $35M | $426M | $1.24B | $76M |
| Cash & Equiv. | $4M | $36M | $124M | $39M |
AWX vs USPH vs CWST vs AFCG — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Mar 21 | May 26 | Return |
|---|---|---|---|
| Avalon Holdings Cor… (AWX) | 100 | 68.9 | -31.1% |
| U.S. Physical Thera… (USPH) | 100 | 56.7 | -43.3% |
| Casella Waste Syste… (CWST) | 100 | 134.4 | +34.4% |
| Advanced Flower Cap… (AFCG) | 100 | 21.5 | -78.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AWX vs USPH vs CWST vs AFCG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
AWX is the clearest fit if your priority is momentum.
- -7.0% vs AFCG's -35.5%
USPH carries the broadest edge in this set and is the clearest fit for income & stability.
- Dividend streak 5 yrs, beta 0.93, yield 3.1%
- Better valuation composite
- 1.5% margin vs AFCG's -333.9%
- 3.1% yield, 5-year raise streak, vs AFCG's 28.1%, (2 stocks pay no dividend)
CWST is the #2 pick in this set and the best alternative if growth exposure and long-term compounding is your priority.
- Rev growth 18.0%, EPS growth -47.8%, 3Y rev CAGR 19.2%
- 10.6% 10Y total return vs AWX's 29.1%
- Lower volatility, beta 0.32, Low D/E 79.0%, current ratio 1.26x
- Beta 0.32, current ratio 1.26x
AFCG lags the leaders in this set but could rank higher in a more targeted comparison.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 18.0% revenue growth vs AFCG's -39.6% | |
| Value | Better valuation composite | |
| Quality / Margins | 1.5% margin vs AFCG's -333.9% | |
| Stability / Safety | Beta 0.32 vs AFCG's 1.86 | |
| Dividends | 3.1% yield, 5-year raise streak, vs AFCG's 28.1%, (2 stocks pay no dividend) | |
| Momentum (1Y) | -7.0% vs AFCG's -35.5% | |
| Efficiency (ROA) | 0.9% ROA vs AFCG's -6.4%, ROIC 5.6% vs -4.1% |
AWX vs USPH vs CWST vs AFCG — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
AWX vs USPH vs CWST vs AFCG — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
AWX leads in 2 of 6 categories
USPH leads 1 • CWST leads 0 • AFCG leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
USPH leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CWST is the larger business by revenue, generating $1.9B annually — 314.8x AFCG's $6M. Profitability is closely matched — net margins range from 1.5% (USPH) to -3.3% (AFCG). On growth, AFCG holds the edge at +64.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $85M | $695M | $1.9B | $6M |
| EBITDAEarnings before interest/tax | $5M | $107M | $414M | -$16M |
| Net IncomeAfter-tax profit | $585,000 | $11M | $7M | -$20M |
| Free Cash FlowCash after capex | $3M | $67M | $102M | -$24M |
| Gross MarginGross profit ÷ Revenue | +15.3% | +22.0% | +17.4% | -76.6% |
| Operating MarginEBIT ÷ Revenue | +3.7% | +12.2% | +4.5% | -124.7% |
| Net MarginNet income ÷ Revenue | +0.7% | +1.5% | +0.4% | -3.3% |
| FCF MarginFCF ÷ Revenue | +4.0% | +9.6% | +5.5% | -3.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +9.9% | +7.7% | +9.6% | +64.7% |
| EPS Growth (YoY)Latest quarter vs prior year | +15.8% | -115.0% | -18.6% | +16.7% |
Valuation Metrics
AWX leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 30.7x trailing earnings, AWX trades at a 96% valuation discount to CWST's 712.1x P/E. On an enterprise value basis, AWX's 7.0x EV/EBITDA is more attractive than CWST's 15.7x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $10M | $897M | $5.4B | $73M |
| Enterprise ValueMkt cap + debt − cash | $41M | $1.3B | $6.5B | $110M |
| Trailing P/EPrice ÷ TTM EPS | 30.74x | 41.55x | 712.08x | -3.25x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 20.63x | 63.93x | — |
| PEG RatioP/E ÷ EPS growth rate | 0.35x | — | — | — |
| EV / EBITDAEnterprise value multiple | 6.97x | 12.52x | 15.74x | — |
| Price / SalesMarket cap ÷ Revenue | 0.12x | 1.15x | 2.91x | 2.32x |
| Price / BookPrice ÷ Book value/share | 0.27x | 1.16x | 3.46x | 0.39x |
| Price / FCFMarket cap ÷ FCF | 4.80x | 14.71x | 63.17x | 6.47x |
Profitability & Efficiency
Evenly matched — AWX and USPH each lead in 4 of 9 comparable metrics.
Profitability & Efficiency
AWX delivers a 1.6% return on equity — every $100 of shareholder capital generates $2 in annual profit, vs $-11 for AFCG. AFCG carries lower financial leverage with a 0.43x debt-to-equity ratio, signaling a more conservative balance sheet compared to AWX's 0.94x. On the Piotroski fundamental quality scale (0–9), AWX scores 6/9 vs AFCG's 4/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +1.6% | +1.4% | +0.5% | -11.1% |
| ROA (TTM)Return on assets | +0.7% | +0.9% | +0.2% | -6.4% |
| ROICReturn on invested capital | +2.2% | +5.6% | +2.6% | -4.1% |
| ROCEReturn on capital employed | +2.8% | +7.6% | +2.9% | -5.6% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 4 | 4 |
| Debt / EquityFinancial leverage | 0.94x | 0.55x | 0.79x | 0.43x |
| Net DebtTotal debt minus cash | $31M | $390M | $1.1B | $38M |
| Cash & Equiv.Liquid assets | $4M | $36M | $124M | $39M |
| Total DebtShort + long-term debt | $35M | $426M | $1.2B | $76M |
| Interest CoverageEBIT ÷ Interest expense | 3.09x | 15.42x | 1.12x | -2.15x |
Total Returns (Dividends Reinvested)
AWX leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CWST five years ago would be worth $12,572 today (with dividends reinvested), compared to $5,539 for AFCG. Over the past 12 months, AWX leads with a -7.0% total return vs AFCG's -35.5%. The 3-year compound annual growth rate (CAGR) favors AWX at -1.8% vs USPH's -17.4% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -9.0% | -24.6% | -13.4% | +10.2% |
| 1-Year ReturnPast 12 months | -7.0% | -14.3% | -28.9% | -35.5% |
| 3-Year ReturnCumulative with dividends | -5.2% | -43.7% | -6.3% | -20.1% |
| 5-Year ReturnCumulative with dividends | -43.9% | -43.4% | +25.7% | -44.6% |
| 10-Year ReturnCumulative with dividends | +29.1% | +22.6% | +1059.4% | -42.4% |
| CAGR (3Y)Annualised 3-year return | -1.8% | -17.4% | -2.2% | -7.2% |
Risk & Volatility
Evenly matched — AWX and CWST each lead in 1 of 2 comparable metrics.
Risk & Volatility
AWX is the less volatile stock with a -0.12 beta — it tends to amplify market swings less than AFCG's 1.86 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CWST currently trades 70.5% from its 52-week high vs AWX's 46.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.12x | 0.93x | 0.32x | 1.86x |
| 52-Week HighHighest price in past year | $5.43 | $93.50 | $121.24 | $5.87 |
| 52-Week LowLowest price in past year | $2.10 | $58.55 | $74.05 | $2.06 |
| % of 52W HighCurrent price vs 52-week peak | +46.6% | +63.1% | +70.5% | +52.6% |
| RSI (14)Momentum oscillator 0–100 | 49.2 | 46.1 | 52.8 | 48.2 |
| Avg Volume (50D)Average daily shares traded | 5K | 171K | 874K | 235K |
Analyst Outlook
Evenly matched — USPH and AFCG each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: USPH as "Buy", CWST as "Buy". Consensus price targets imply 72.9% upside for USPH (target: $102) vs 39.3% for CWST (target: $119). For income investors, AFCG offers the higher dividend yield at 28.10% vs USPH's 3.06%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | — |
| Price TargetConsensus 12-month target | — | $102.00 | $119.00 | — |
| # AnalystsCovering analysts | — | 12 | 19 | — |
| Dividend YieldAnnual dividend ÷ price | — | +3.1% | — | +28.1% |
| Dividend StreakConsecutive years of raises | 1 | 5 | 1 | 0 |
| Dividend / ShareAnnual DPS | — | $1.80 | — | $0.87 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.6% | 0.0% | 0.0% |
AWX leads in 2 of 6 categories (Valuation Metrics, Total Returns). USPH leads in 1 (Income & Cash Flow). 3 tied.
AWX vs USPH vs CWST vs AFCG: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is AWX or USPH or CWST or AFCG a better buy right now?
For growth investors, Casella Waste Systems, Inc.
(CWST) is the stronger pick with 18. 0% revenue growth year-over-year, versus -39. 6% for Advanced Flower Capital Inc. (AFCG). Avalon Holdings Corporation (AWX) offers the better valuation at 30. 7x trailing P/E, making it the more compelling value choice. Analysts rate U. S. Physical Therapy, Inc. (USPH) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — AWX or USPH or CWST or AFCG?
On trailing P/E, Avalon Holdings Corporation (AWX) is the cheapest at 30.
7x versus Casella Waste Systems, Inc. at 712. 1x. On forward P/E, U. S. Physical Therapy, Inc. is actually cheaper at 20. 6x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — AWX or USPH or CWST or AFCG?
Over the past 5 years, Casella Waste Systems, Inc.
(CWST) delivered a total return of +25. 7%, compared to -44. 6% for Advanced Flower Capital Inc. (AFCG). Over 10 years, the gap is even starker: CWST returned +1059% versus AFCG's -42. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — AWX or USPH or CWST or AFCG?
By beta (market sensitivity over 5 years), Avalon Holdings Corporation (AWX) is the lower-risk stock at -0.
12β versus Advanced Flower Capital Inc. 's 1. 86β — meaning AFCG is approximately -1643% more volatile than AWX relative to the S&P 500. On balance sheet safety, Advanced Flower Capital Inc. (AFCG) carries a lower debt/equity ratio of 43% versus 94% for Avalon Holdings Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — AWX or USPH or CWST or AFCG?
By revenue growth (latest reported year), Casella Waste Systems, Inc.
(CWST) is pulling ahead at 18. 0% versus -39. 6% for Advanced Flower Capital Inc. (AFCG). On earnings-per-share growth, the picture is similar: U. S. Physical Therapy, Inc. grew EPS -22. 8% year-over-year, compared to -218. 8% for Advanced Flower Capital Inc.. Over a 3-year CAGR, CWST leads at 19. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — AWX or USPH or CWST or AFCG?
U.
S. Physical Therapy, Inc. (USPH) is the more profitable company, earning 1. 9% net margin versus -66. 0% for Advanced Flower Capital Inc. — meaning it keeps 1. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: USPH leads at 10. 3% versus -43. 6% for AFCG. At the gross margin level — before operating expenses — AFCG leads at 90. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is AWX or USPH or CWST or AFCG more undervalued right now?
On forward earnings alone, U.
S. Physical Therapy, Inc. (USPH) trades at 20. 6x forward P/E versus 63. 9x for Casella Waste Systems, Inc. — 43. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for USPH: 72. 9% to $102. 00.
08Which pays a better dividend — AWX or USPH or CWST or AFCG?
In this comparison, AFCG (28.
1% yield), USPH (3. 1% yield) pay a dividend. AWX, CWST do not pay a meaningful dividend and should not be held primarily for income.
09Is AWX or USPH or CWST or AFCG better for a retirement portfolio?
For long-horizon retirement investors, Casella Waste Systems, Inc.
(CWST) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 32), +1059% 10Y return). Advanced Flower Capital Inc. (AFCG) carries a higher beta of 1. 86 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CWST: +1059%, AFCG: -42. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between AWX and USPH and CWST and AFCG?
These companies operate in different sectors (AWX (Industrials) and USPH (Healthcare) and CWST (Industrials) and AFCG (Real Estate)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: AWX is a small-cap quality compounder stock; USPH is a small-cap high-growth stock; CWST is a small-cap high-growth stock; AFCG is a small-cap income-oriented stock. USPH, AFCG pay a dividend while AWX, CWST do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.